Amedeo Smart

Free Medical Literature Service



Venous Thrombosis

  Free Subscription

Articles published in
Am J Hematol
    May 2024
  1. SIDDIQUI F, Tafur A, Hussain M, Garcia-Ortega A, et al
    The prognostic value of blood cellular indices in pulmonary embolism.
    Am J Hematol. 2024 May 30. doi: 10.1002/ajh.27379.
    >> Share

  2. SARTORI M, Iotti M, Camporese G, Siragusa S, et al
    Six-week low-molecular-weight heparin versus 12-week warfarin for calf deep vein thrombosis: A randomized, prospective, open-label study.
    Am J Hematol. 2024;99:854-861.
    >> Share

    April 2024
  3. MA S, La J, Swinnerton KN, Guffey D, et al
    Thrombosis risk prediction in lymphoma patients: A multi-institutional, retrospective model development and validation study.
    Am J Hematol. 2024 Apr 23. doi: 10.1002/ajh.27335.
    >> Share

    March 2024
  4. COSTA BA, Costa TA, Saravia SD, Felix N, et al
    Thromboembolic risk of carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for newly diagnosed multiple myeloma: A comparative systematic review and meta-analysis.
    Am J Hematol. 2024 Mar 15. doi: 10.1002/ajh.27288.
    >> Share

    January 2024
  5. ROY DC, Wang TF, Lun R, Zharai A, et al
    Inherited thrombophilia gene mutations and risk of venous thromboembolism in patients with cancer: A systematic review and meta-analysis.
    Am J Hematol. 2024 Jan 30. doi: 10.1002/ajh.27222.
    >> Share

    October 2023
  6. GUE YX, Lip GYH
    Increased risk of venous thromboembolism in patients with gastrointestinal disorders.
    Am J Hematol. 2023 Oct 19. doi: 10.1002/ajh.27140.
    >> Share

    September 2023
  7. YUAN S, Sun Y, Chen J, Li X, et al
    Long-term risk of venous thromboembolism among patients with gastrointestinal non-neoplastic and neoplastic diseases: A prospective cohort study of 484 211 individuals.
    Am J Hematol. 2023 Sep 27. doi: 10.1002/ajh.27106.
    >> Share

    August 2023
  8. AGARWAL S, Stanek JR, Vesely SK, Creary SE, et al
    Pregnancy-related thromboembolism in women with sickle cell disease: An analysis of National Medicaid Data.
    Am J Hematol. 2023 Aug 8. doi: 10.1002/ajh.27045.
    >> Share

    June 2023
  9. GIORGIO K, Walker RF, MacLehose RF, Adrianzen-Herrera D, et al
    Venous thromboembolism mortality and trends in older US adults, 2011-2019.
    Am J Hematol. 2023 Jun 27. doi: 10.1002/ajh.26996.
    >> Share

  10. WANG TF, Grubic N, Carrier M, Canney M, et al
    Risk of venous thromboembolism or hemorrhage among individuals with chronic kidney disease on prophylactic anticoagulant after hip or knee arthroplasty.
    Am J Hematol. 2023 Jun 21. doi: 10.1002/ajh.26994.
    >> Share

    May 2023
  11. LI A, May SB, La J, Martens KL, et al
    Venous thromboembolism risk in cancer patients receiving first-line immune checkpoint inhibitor versus chemotherapy.
    Am J Hematol. 2023 May 10. doi: 10.1002/ajh.26954.
    >> Share

    January 2023
  12. HOUGHTON DE, Wysokinski WE, Padrnos LJ, Shah S, et al
    Venous Thromboembolism after COVID-19 Vaccination in Patients with Thrombophilia.
    Am J Hematol. 2023 Jan 20. doi: 10.1002/ajh.26848.
    >> Share

    July 2022
  13. XIAOHUA L, Liu Y, Qu C, Mol B, et al
    The association of iron deficiency anemia, thrombocytosis at delivery and postpartum venous thromboembolism.
    Am J Hematol. 2022 Jul 9. doi: 10.1002/ajh.26657.
    >> Share

    May 2022
  14. DA COSTA WL JR, Guffey D, Oluyomi A, Bandyo R, et al
    Patterns of venous thromboembolism risk, treatment, and outcomes among patients with cancer from uninsured and vulnerable populations.
    Am J Hematol. 2022 May 31. doi: 10.1002/ajh.26623.
    >> Share

    March 2022
  15. BERG S, Kim SH, Wozniak A, Odetola O, et al
    COVID-19 Thromboembolism Incidence, Risk Factors and Anticoagulation Practices from a Chicago Metropolitan US Population.
    Am J Hematol. 2022 Mar 18. doi: 10.1002/ajh.26541.
    >> Share

  16. LI A, Martens KL, Nguyen D, Basom R, et al
    External Validation of the HIGH-2-LOW Model: A Predictive Score for Venous Thromboembolism after Allogeneic Transplant.
    Am J Hematol. 2022 Mar 9. doi: 10.1002/ajh.26521.
    >> Share

    November 2021
  17. GERBER GF, DeZern AE, Chaturvedi S, Brodsky RA, et al
    A 15-year, single institution experience of anticoagulation management in paroxysmal nocturnal hemoglobinuria patients on terminal complement inhibition with history of thromboembolism.
    Am J Hematol. 2021 Nov 20. doi: 10.1002/ajh.26414.
    >> Share

    October 2021
  18. FENYVES BG, Mehta A, Kays KR, Beakes C, et al
    Plasma P-selectin is an early marker of thromboembolism in COVID-19.
    Am J Hematol. 2021 Oct 8. doi: 10.1002/ajh.26372.
    >> Share

    June 2021
  19. ABOU-ISMAIL MY, Moser KA, Smock KJ, Lim MY, et al
    Vaccine-induced thrombotic thrombocytopenia following Ad26.COV2.S vaccine in a man presenting as acute venous thromboembolism.
    Am J Hematol. 2021 Jun 7. doi: 10.1002/ajh.26265.
    >> Share

  20. TEFFERI A, Szuber N, Pardanani A, Hanson CA, et al
    Extreme thrombocytosis in low-risk essential thrombocythemia: Retrospective review of vascular events and treatment strategies.
    Am J Hematol. 2021;96:E182-E184.
    >> Share

    May 2021
  21. KRECAK I, Gardijan B, Brkicic J, Grubisic-Cabo R, et al
    Cryptic brain abscess - do not forget hereditary hemorrhagic teleangiectasia!
    Am J Hematol. 2021;96:640-642.
    >> Share

    April 2021
  22. ARCHULETA J, van der Graaf M, Kaptein FHJ, Althaus L, et al
    Sudden death due to massive bone marrow sequestration crisis in a patient with sickle cell disease.
    Am J Hematol. 2021;96:E100-E102.
    >> Share

    March 2021
  23. WARKENTIN TE, Smythe MA, Ali MA, Aslam N, et al
    Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT?
    Am J Hematol. 2021;96:320-329.
    >> Share

    December 2020
  24. HANFF TC, Mohareb AM, Giri J, Cohen JB, et al
    Thrombosis in COVID-19.
    Am J Hematol. 2020;95:1578-1589.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016